MKI67 and neoplasm: For “tumour penetration,” we observed a decreasing expression of Ki-67 from the pT1 (79.3%) to pT3 (68.1%) tumours and then a rise in expression for adenocarcinoma with invasion of other organs or structures (pT4) (73.1%).